What is ALS Phase 3 Study Ceftriaxone?

Category: Others

false

See also: Clinical Trial

NCT00349622 is a clinical trial with ceftriaxone in subjects with amyotrophic lateral sclerosis (ALS). Other study IDs include: U01NS049640-02, NINDS, U01NS049640-02, NINDS CRC.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 2
Moderate 11
Mild 6
None 15

Commonly reported side effects and conditions associated with ALS Phase 3 Study Ceftriaxone

Side effect Patients
Gallstones 3
Beginning of gallstones 2
Yeast Infection (candida) 2
Acid reflux 1
biliary stone 1
Candidiasis (yeast infection) 1

Show all 17 reported side effects

Why patients stopped taking ALS Phase 3 Study Ceftriaxone

Multiple reasons could be selected

Reason Patients
Course of treatment ended 4
Side effects too severe 4
Doctor's advice 3
Other 2
Did not seem to work 1
See all 11 patients who’ve stopped using ALS Phase 3 Study Ceftriaxone

Duration

Stopped using ALS Phase 3 Study Ceftriaxone

Duration Patients
0-1 month 2
6 months-1 year 2
1-2 years 6
2 years or more 1
Adherence
Adherence Evaluations
Always 29
Usually 3
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations
Very hard to take 6
Somewhat hard to take 17
A little hard to take 9
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 3
$100-199 0
$50-99 0
$25-49 0
< $25 22
Not specified 9
Last updated:

2 patient evaluations for ALS Phase 3 Study Ceftriaxone

16 members have decided to share their profiles only with other members of PatientsLikeMe.

7573
Portrait default thumb
7573
Sex: F
Data Quality: 1 star
Bulbar: mild
Arms: mild
Chest: mild
Legs: moderate
I am: g
I have:
ALS

See 7573's full ALS Phase 3 Study Ceftriaxone history

Apr 29, 2011 (Started Oct 22, 2010)

  • Effectiveness
    Can’t tell (for ALS (Amyotrophic Lateral Sclerosis))
  • side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 other Daily
Advice & Tips: I take this treatment twice a day. People tell me that my ALS is moving slower.
Cost: < $25 monthly

Mar 4, 2011 (Started Oct 22, 2010)

  • Effectiveness
    Can’t tell (for ALS (Amyotrophic Lateral Sclerosis))
  • side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 1 other Daily
Advice & Tips: I think this is a good study. We set a time each morning to take the medication, and it is no problem for us. I feel I swallow better when I am on the medication. Taking this medication is an adjustment to my life, but so is ALS and if this is going help me, I'll do it.
Cost: < $25 monthly

  • 0 helpful marks
moolaw
27024 thumb
moolaw
Sex: F
Data Quality: 0 stars
Bulbar: moderate
Arms: severe
Chest: moderate
Legs: severe
I am: b
I have:
ALS

See moolaw's full ALS Phase 3 Study Ceftriaxone history

Dec 20, 2010 (Started Oct 11, 2010)

  • Effectiveness
    Can’t tell (for Participate in clinical trial)
  • side effects
    Mild (Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive)
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 mg Daily
Advice & Tips: It's no problem for me, but my husband has so much to do that he forgets to thaw the medicine sometimes.
Cost: < $25 monthly
Side effects: Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive

Nov 20, 2010 (Started Oct 11, 2010)

  • Effectiveness
    None (for Participate in clinical trial)
  • side effects
    Moderate (Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive)
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 mg Daily
Advice & Tips: I feel like I'm getting worse more quickly, but don't know whether it is the study drug or riluzole.
Cost: < $25 monthly
Side effects: Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive

Oct 21, 2010 (Started Oct 11, 2010)

  • Effectiveness
    Can’t tell (for Participate in clinical trial)
  • side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 4 g Daily
Advice & Tips: I was afraid that the procedures for administering the drug would be difficult, but it isn't too hard for my husband to do and it is easy to schedule early in the morning and then before bed. I feel good about participating in a trial.
Cost: < $25 monthly
Side effects: Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for ALS Phase 3 Study Ceftriaxone